QUEST DIAGNOSTICS INC (DGX) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:DGX - US74834L1008 - Common Stock
DGX Key Statistics, Chart & Performance
The current stock price of DGX is 178.14 USD. In the past month the price decreased by -2.02%. In the past year, price increased by 17.36%.
DGX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.65 | 101.29B | ||
| CI | THE CIGNA GROUP | 9.82 | 74.56B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 130.52 | 24.01B | ||
| LH | LABCORP HOLDINGS INC | 16.04 | 21.03B | ||
| GH | GUARDANT HEALTH INC | N/A | 14.16B | ||
| HIMS | HIMS & HERS HEALTH INC | 65.67 | 8.07B | ||
| DVA | DAVITA INC | 12.03 | 7.84B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 38.74 | 7.13B | ||
| CHE | CHEMED CORP | 19.97 | 6.22B | ||
| RDNT | RADNET INC | 203.71 | 5.97B | ||
| OPCH | OPTION CARE HEALTH INC | 21.7 | 5.13B | ||
| BLLN | BILLIONTOONE INC CL A | N/A | 4.06B |
Related stock screener links
About DGX
Company Profile
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. The company is headquartered in Secaucus, New Jersey and currently employs 45,000 full-time employees. The firm provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. The company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. The company offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The company also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
Company Info
QUEST DIAGNOSTICS INC
500 Plaza Drive
Secaucus NEW JERSEY 07094 US
CEO: Stephen H. Rusckowski
Employees: 45000
Phone: 19735202700
QUEST DIAGNOSTICS INC / DGX FAQ
Can you describe the business of QUEST DIAGNOSTICS INC?
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. The company is headquartered in Secaucus, New Jersey and currently employs 45,000 full-time employees. The firm provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. The company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. The company offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The company also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
Can you provide the latest stock price for QUEST DIAGNOSTICS INC?
The current stock price of DGX is 178.14 USD. The price decreased by -1.29% in the last trading session.
What is the dividend status of QUEST DIAGNOSTICS INC?
QUEST DIAGNOSTICS INC (DGX) has a dividend yield of 1.84%. The yearly dividend amount is currently 2.98.
What is the ChartMill rating of QUEST DIAGNOSTICS INC stock?
DGX has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the GICS sector and industry of DGX stock?
QUEST DIAGNOSTICS INC (DGX) operates in the Health Care sector and the Health Care Providers & Services industry.
Is QUEST DIAGNOSTICS INC (DGX) expected to grow?
The Revenue of QUEST DIAGNOSTICS INC (DGX) is expected to grow by 11.72% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the market capitalization of DGX stock?
QUEST DIAGNOSTICS INC (DGX) has a market capitalization of 19.82B USD. This makes DGX a Large Cap stock.
DGX Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to DGX. When comparing the yearly performance of all stocks, DGX turns out to be only a medium performer in the overall market: it outperformed 56.89% of all stocks.
DGX Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to DGX. DGX has an excellent profitability rating, but there are some minor concerns on its financial health.
DGX Financial Highlights
Over the last trailing twelve months DGX reported a non-GAAP Earnings per Share(EPS) of 9.76. The EPS increased by 10.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.88% | ||
| ROA | 5.95% | ||
| ROE | 13.27% | ||
| Debt/Equity | 0.71 |
DGX Forecast & Estimates
24 analysts have analysed DGX and the average price target is 201.37 USD. This implies a price increase of 13.04% is expected in the next year compared to the current price of 178.14.
For the next year, analysts expect an EPS growth of 9.8% and a revenue growth 11.72% for DGX